Chaudhary R, Moorhead G, Park R, Li J, et al. Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer. Clin Cancer Res 2025 Oct 21. doi: 10.1158/1078-0432.CCR-25-2201.
PMID: 41117857